Here you will find our non-confidential licensing portfolio.
We build up our portfolio by aligning our scientific knowledge and industry needs with a market-driven focus.
For additional information on each project, please contact us at email@example.com.
First-in-class molecule that specifically targets mechanotransduction for cancer therapy
Light-regulated drugs to restore sight
Novel depigmenting treatment
Calcium nanoparticle-based biodegradable material with controllable ion release properties for wound healing applications
MIMETIC LYMPH NODES
Synthetic lymph nodes made of biocompatible and 3D-printable polymer matrix that enable cell proliferation and expansion for adoptive cellular cancer immunotherapy
Bioink for cell therapy
In vitro diagnostic device to monitor biofilm growth
An innovative device for personalised diagnosis and therapy monitoring for genitourinary cancers
Point-of-care device for monitoring of disease-related antibodies
Width-controlled 3D bioprinting of thin and homogeneous biomimetic fibres
Stereolithographic 3D bioprinting
Ready-to-use cell culture plates for gut 3D models
Micro Immuno Response On a Chip
Early detection, assessment, and management of sleep disorders at home
Drone for measuring the concentration of odour